BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15254434)

  • 21. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
    Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
    J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 and p73: seeing double?
    Soengas MS; Lowe SW
    Nat Genet; 2000 Dec; 26(4):391-2. PubMed ID: 11101828
    [No Abstract]   [Full Text] [Related]  

  • 23. p53 Protein is activated by Pin1: and also by Cu-SOD prion-like enzyme.
    Wiseman A
    Med Hypotheses; 2005; 65(1):32-4. PubMed ID: 15893113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decursin exerts anti-cancer activity in MDA-MB-231 breast cancer cells via inhibition of the Pin1 activity and enhancement of the Pin1/p53 association.
    Kim JH; Jung JH; Kim SH; Jeong SJ
    Phytother Res; 2014 Feb; 28(2):238-44. PubMed ID: 23580332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes.
    Costanzo A; Merlo P; Pediconi N; Fulco M; Sartorelli V; Cole PA; Fontemaggi G; Fanciulli M; Schiltz L; Blandino G; Balsano C; Levrero M
    Mol Cell; 2002 Jan; 9(1):175-86. PubMed ID: 11804596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prolyl isomerase Pin1 affects Che-1 stability in response to apoptotic DNA damage.
    De Nicola F; Bruno T; Iezzi S; Di Padova M; Floridi A; Passananti C; Del Sal G; Fanciulli M
    J Biol Chem; 2007 Jul; 282(27):19685-91. PubMed ID: 17468107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin.
    Grison A; Mantovani F; Comel A; Agostoni E; Gustincich S; Persichetti F; Del Sal G
    Proc Natl Acad Sci U S A; 2011 Nov; 108(44):17979-84. PubMed ID: 22011578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the TP73 gene and its transcripts in neuro-oncology.
    Jancalek R
    Br J Neurosurg; 2014 Oct; 28(5):598-605. PubMed ID: 24742294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic prospects for p73 and p63: rising from the shadow of p53.
    Vilgelm A; El-Rifai W; Zaika A
    Drug Resist Updat; 2008; 11(4-5):152-63. PubMed ID: 18801697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells.
    Reineke EL; Lam M; Liu Q; Liu Y; Stanya KJ; Chang KS; Means AR; Kao HY
    Mol Cell Biol; 2008 Feb; 28(3):997-1006. PubMed ID: 18039859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of phosphorylated proteins involved in the oncogenesis of prostate cancer via Pin1-proteomic analysis.
    Endoh K; Nishi M; Ishiguro H; Uemura H; Miyagi Y; Aoki I; Hirano H; Kubota Y; Ryo A
    Prostate; 2012 May; 72(6):626-37. PubMed ID: 21809350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of cellular senescence and differentiation by prolyl isomerase Pin1 in cardiac progenitor cells.
    Toko H; Hariharan N; Konstandin MH; Ormachea L; McGregor M; Gude NA; Sundararaman B; Joyo E; Joyo AY; Collins B; Din S; Mohsin S; Uchida T; Sussman MA
    J Biol Chem; 2014 Feb; 289(9):5348-56. PubMed ID: 24375406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma.
    Teng BL; Hacker KE; Chen S; Means AR; Rathmell WK
    Mol Oncol; 2011 Oct; 5(5):465-74. PubMed ID: 21764651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting peptidyl-prolyl isomerase pin1 to inhibit tumor cell aggressiveness.
    Beretta GL; De Cesare M; Albano L; Magnifico A; Carenini N; Corna E; Perego P; Gatti L
    Tumori; 2016; 102(2):144-9. PubMed ID: 26917410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage.
    Berger M; Stahl N; Del Sal G; Haupt Y
    Mol Cell Biol; 2005 Jul; 25(13):5380-8. PubMed ID: 15964795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.
    Girardini JE; Napoli M; Piazza S; Rustighi A; Marotta C; Radaelli E; Capaci V; Jordan L; Quinlan P; Thompson A; Mano M; Rosato A; Crook T; Scanziani E; Means AR; Lozano G; Schneider C; Del Sal G
    Cancer Cell; 2011 Jul; 20(1):79-91. PubMed ID: 21741598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p73 in apoptosis.
    Stiewe T; Pützer BM
    Apoptosis; 2001 Dec; 6(6):447-52. PubMed ID: 11595834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability.
    Yeh ES; Lew BO; Means AR
    J Biol Chem; 2006 Jan; 281(1):241-51. PubMed ID: 16223725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolyl isomerase PIN1 regulates DNA double-strand break repair by counteracting DNA end resection.
    Steger M; Murina O; Hühn D; Ferretti LP; Walser R; Hänggi K; Lafranchi L; Neugebauer C; Paliwal S; Janscak P; Gerrits B; Del Sal G; Zerbe O; Sartori AA
    Mol Cell; 2013 May; 50(3):333-43. PubMed ID: 23623683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.